Matinas BioPharma Holdings (MTNB) Acquisitions (2015)

Matinas BioPharma Holdings (MTNB) reported Acquisitions of -$70754.0 for Q1 2015.

Matinas BioPharma Holdings (MTNB) Acquisitions (2015) Analysis & Trends

Matinas BioPharma Holdings (MTNB) has 1 years of Acquisitions data on file, last reported at -$70754.0 in Q1 2015.

  • Acquisitions for Q1 2015 came in at -$70754.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2015 was -$70754.0 (changed N/A YoY), and the FY2015 annual result was -$70754.0, changed N/A from the prior year.
  • Acquisitions was little changed at -$70754.0 in Q1 2015 per MTNB's latest filing.
  • Over five years, Acquisitions peaked at -$70754.0 in Q1 2015 and troughed at -$70754.0 in Q1 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Matinas BioPharma Holdings 4.60 Mn 2.15 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2015 -70,754.00